Nonalcoholic fatty liver disease and statins

摘要: Abstract Objective Nonalcoholic fatty liver disease (NAFLD) is the most frequent cause of elevated transaminase levels and affects approximately one third general population. Patients with NAFLD are at increased risk for cardiovascular events, which represent leading death in this We discuss safety efficacy statins Materials/methods reviewed recent literature on patients their effects histology events. Results It appears that can be safely administered to NAFLD, including those ( Conclusions Statins appear safe might also reduce events NAFLD. Ongoing future studies will clarify whether have a role treatment